
XTL Biopharmaceuticals Ltd. (XTLB)
- Previous Close
2.3100 - Open
3.8000 - Bid 2.6300 x 200
- Ask 4.3600 x 200
- Day's Range
3.2200 - 4.8700 - 52 Week Range
2.1200 - 10.2800 - Volume
113,444,310 - Avg. Volume
11,228 - Market Cap (intraday)
8.422M - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
-- - EPS (TTM)
-3.6000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: XTLB
View MorePerformance Overview: XTLB
Trailing total returns as of 4/29/2026, which may include dividends or other distributions. Benchmark is TA-125 (^TA125.TA) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: XTLB
View MoreStatistics: XTLB
View MoreValuation Measures
-
Market Cap
5.72M
-
Enterprise Value
5.55M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
5.18
-
Price/Book (mrq)
0.97
-
Enterprise Value/Revenue
5.73
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-240.56%
-
Return on Equity (ttm)
-577.13%
-
Revenue (ttm)
968k
-
Net Income Avi to Common (ttm)
-6.31M
-
Diluted EPS (ttm)
-3.6000
Balance Sheet and Cash Flow
-
Total Cash (mrq)
259k
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
--
Compare To: XTLB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.

